Caroline Baumal, M.D., is the Chief Medical Officer at Apellis Pharmaceuticals, Inc. since January 2023. She brings over 25 years of experience in the field of medicine, particularly in ophthalmology as a vitreoretinal surgeon and professor at the New England...

Caroline Baumal, M.D., is the Chief Medical Officer at Apellis Pharmaceuticals, Inc. since January 2023. She brings over 25 years of experience in the field of medicine, particularly in ophthalmology as a vitreoretinal surgeon and professor at the New England Eye Center. Caroline was recognized as a key opinion leader in retinal imaging and therapeutics, making significant strides in areas like ophthalmic devices and drug delivery. Prior to her role in Apellis, she led numerous clinical studies, adding to her extensive expertise. Caroline received her M.D. and B.Sc. from well-respected institutions and completed specialized fellowships in vitreoretinal surgery. Her salary in 2023 was $550,673, which reflects performance achievements, as she was awarded a bonus of $323,438 based on reaching key corporate goals. Currently, she holds equity in the company, further aligning her interests with Apellis’s success in biopharmaceuticals. Caroline’s appointment came at a pivotal time for the company, right when they were gearing up for significant product developments. Her clinical background plays a crucial role in guiding Apellis as they advance their mission in innovative therapeutics.